---
title: "Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program | ONNVF Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288484272.md"
description: "Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program | ONNVF Stock News"
datetime: "2026-06-02T14:01:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288484272.md)
  - [en](https://longbridge.com/en/news/288484272.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288484272.md)
generator: "portal-rs"
---

# Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program | ONNVF Stock News

Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program | ONNVF Stock News

### Related Stocks

- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)

## Related News & Research

- [ONCO: Q2 2026 revenue up 62% YoY, with strong margins and EMA review for label expansion ongoing](https://longbridge.com/en/news/297137606.md)
- [Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Enters LOI for Exclusive Option on LAG-3 Inhibitor Program](https://longbridge.com/en/news/296513179.md)
- [Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Foundation for Biomarker-Driven Cancer Therapy](https://longbridge.com/en/news/296130343.md)
- [Onco-Innovations identifies non-tin catalyst to advance ONC010 polymer development](https://longbridge.com/en/news/295714977.md)
- [Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program | ONNVF Stock News](https://longbridge.com/en/news/296407884.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**